SCHEMBL9921370

SCHEMBL9921370

COc1ccccc1CCNc1ncnc2ccc(F)cc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 10/20 0.59
CYP1A2 P05177 11/20 0.58
CYP3A4 P08684 11/20 0.58
CYP2D6 P10635 11/20 0.58
LMNA P02545 10/20 0.58
CYP2C19 P33261 10/20 0.58
HSD17B10 Q99714 9/20 0.58
ALDH1A1 P00352 9/20 0.58
TSHR P16473 8/20 0.58
USP2 O75604 8/20 0.58
CLK4 Q9HAZ1 7/20 0.58
HIF1A Q16665 7/20 0.58
CYP2C9 P11712 6/20 0.58
HTT P42858 1/20 0.58
BRD4 O60885 1/20 0.56
EGFR P00533 1/20 0.56
ERBB2 P04626 1/20 0.56
ERBB4 Q15303 1/20 0.56
APP P05067 1/20 0.56
SMN1; SMN2 Q16637 4/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8483285 0.87 APP (0.68) MAPK1CYP1A2CYP3A4CYP2D6LMNA
SCHEMBL9921376 0.86 HTT (0.60) MAPK1CYP1A2CYP3A4CYP2D6LMNA
SCHEMBL9921372 0.85 HTT (0.62) MAPK1CYP1A2CYP2D6LMNAHTT
SCHEMBL13191856 0.83 HTT (0.67) MAPK1LMNAHTTEGFRAPP
SCHEMBL9921371 0.83 HTT (0.60) MAPK1CYP1A2CYP3A4CYP2D6LMNA
SCHEMBL9921350 0.81 HTT (0.58) MAPK1CYP1A2CYP3A4CYP2D6LMNA
SCHEMBL9921375 0.80 HTT (0.65) MAPK1CYP1A2CYP2D6LMNAHTT
SCHEMBL9921359 0.80 HTT (0.72) MAPK1LMNACLK4HTTEGFR
SCHEMBL8498739 0.80 LDHA (0.57) MAPK1CYP1A2CYP3A4CYP2D6LMNA
SCHEMBL9921373 0.80 CLK4 (0.63) MAPK1CYP1A2CYP3A4CYP2D6LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120258975-A1 Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY (CN) 2012-10-11 US disclosed
US-20120258975-A1 Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY (CN) 2012-10-11 US disclosed
WO-2012079079-A1 PRODUCTION OF INDUCED PLURIPOTENT STEM CELLS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-06-14 WO disclosed
WO-2011011522-A2 POTENT SMALL MOLECULE INHIBITORS OF AUTOPHAGY, AND METHODS OF USE THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2011-01-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120258975-A1 Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof ATG7, BECN1, SQSTM1 MAPK1 310/4885CYP1A2 4274/4885CYP3A4 4069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.